Investigating patient exclusion bias in meta-analysis.
暂无分享,去创建一个
[1] M. Parmar,et al. Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.
[2] J M Lachin,et al. Statistical considerations in the intent-to-treat principle. , 2000, Controlled clinical trials.
[3] G. Guyatt,et al. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis , 2002, BMJ : British Medical Journal.
[4] Kenneth F Schulz,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Exclusions before Randomisation Exclusions after Randomisation Sample Size Slippages in Randomised Trials: Exclusions and the Lost and Wayward , 2022 .
[5] D Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.
[6] L. Stewart,et al. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials , 2002, The Lancet.
[7] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[8] David Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials , 2001, BMC Medical Research Methodology.
[9] Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. , 2000, The Cochrane database of systematic reviews.
[10] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.
[11] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[12] L. Stewart,et al. To IPD or not to IPD? , 2002, Evaluation & the health professions.
[13] R. J. Hayes,et al. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology , 1996, BMJ.
[14] D. Alberts,et al. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group. , 1991, BMJ.
[15] P. Fayers,et al. Thirty years of Medical Research Council randomized trials in solid tumours. , 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).
[16] D. G. Altman,et al. Randomisation and baseline comparisons in clinical trials , 1990, The Lancet.
[17] Marion Kee,et al. Analysis , 2004, Machine Translation.
[18] M. Parmar,et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). , 1998, International journal of radiation oncology, biology, physics.
[19] L. Stewart,et al. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. , 1995, Statistics in medicine.
[20] D. Alberts,et al. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. , 1998, British Journal of Cancer.
[21] A. Walker,et al. Improving the quality of reporting in randomised controlled trials. , 2004, Journal of wound care.
[22] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[23] S. Casswell,et al. What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999 .
[24] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[25] D. Machin,et al. Intention to treat--who should use ITT? , 1993, British Journal of Cancer.
[26] M Egger,et al. Value of flow diagrams in reports of randomized controlled trials. , 2001, JAMA.
[27] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[28] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[29] B. Phillips. Randomisation. , 1991, Archives of disease in childhood.